Wetzel Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,688
Closed -$260K 133
2025
Q4
$260K Sell
2,688
-65
-2% -$6.31K 0.11% 111
2025
Q3
$264K Sell
2,753
-159
-5% -$14.6K 0.11% 102
2025
Q2
$256K Sell
2,912
-564
-16% -$47.8K 0.12% 104
2025
Q1
$315K Buy
3,476
+25
+0.7% +$2.24K 0.16% 93
2024
Q4
$278K Buy
3,451
+7
+0.2% +$606 0.14% 103
2024
Q3
$312K Buy
3,444
+293
+9% +$24.6K 0.16% 90
2024
Q2
$275K Sell
3,151
-274
-8% -$22.5K 0.16% 93
2024
Q1
$271K Sell
3,425
-2
-0.1% -$171 0.16% 93
2023
Q4
$282K Buy
+3,427
New +$261K 0.17% 89

Other funds holding MDT

Wetzel Investment Advisors's MDT Position: Q1 2026 in Review

Wetzel Investment Advisors sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,688 shares — an estimated $260K sold.

Wetzel Investment Advisors first reported a position in MDT in Q4 2023 and held it in 9 quarters. The position peaked at $315K in Q1 2025. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Wetzel Investment Advisors reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Wetzel Investment Advisors sold 2,688 Medtronic shares in Q1 2026, an estimated $260K.
  • Wetzel Investment Advisors first reported a position in Medtronic in Q4 2023 and held it in 9 quarters.
  • Wetzel Investment Advisors's Medtronic position peaked at $315K in Q1 2025.
  • 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Wetzel Investment Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.